Back
Direxion Daily S&P Biotech Bear 3X Shares Vs. Nebius Group NV Industry Stock Comparison
Sell
23
LABD
Direxion Daily S&P Biotech Bear 3X Shares
Last Price:
$21.22
Seasonality Move:
-0.37%
Sell
33
NBIS
Nebius Group NV
Last Price:
$82.22
Seasonality Move:
-3.81%
Sell
23
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $21.05. The Score for LABD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $87.69. The Score for NBIS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X Shares share price today is $21.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing slight selling pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $87.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.
LABD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.36 | Sell |
| Relative Strength Index (14 RSI): | 33.65 | Sell |
| Chaikin Money Flow: | -1110575 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.18 - 27.28) | Sell |
| Bollinger Bands (100): | (26.49 - 56.39) | Sell |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.69 | Sell |
| Relative Strength Index (14 RSI): | 40.93 | Sell |
| Chaikin Money Flow: | -10263420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.51 - 101.97) | Sell |
| Bollinger Bands (100): | (69.11 - 115.93) | Sell |
LABD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.28 | Sell |
| 20-day SMA: | 23.14 | Sell |
| 50-day SMA: | 28.2 | Sell |
| 200-day SMA: | 62.13 | Sell |
| 8-day EMA: | 21.56 | Sell |
| 20-day EMA: | 23.35 | Sell |
| 50-day EMA: | 29.39 | Sell |
| 200-day EMA: | 52.24 | Sell |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.51 | Sell |
| 20-day SMA: | 93.1 | Sell |
| 50-day SMA: | 107.39 | Sell |
| 200-day SMA: | 63.92 | Buy |
| 8-day EMA: | 94.3 | Sell |
| 20-day EMA: | 96.51 | Sell |
| 50-day EMA: | 98.74 | Sell |
| 200-day EMA: | 73.21 | Buy |
Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.
Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||